Shares of the small-cap biotech Intercept Pharmaceuticals (NASDAQ: ICPT) sank by a noteworthy 19% during the first six months of 2021, according to data from S&P Global Market Intelligence. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback